Benjamin F. Edwards & Company Inc. Buys 471 Shares of Steris PLC (NYSE:STE)

Share on StockTwits

Benjamin F. Edwards & Company Inc. lifted its stake in shares of Steris PLC (NYSE:STE) by 4.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,740 shares of the medical equipment provider’s stock after acquiring an additional 471 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in Steris were worth $1,552,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in STE. Raymond James Trust N.A. lifted its holdings in Steris by 2.8% in the 2nd quarter. Raymond James Trust N.A. now owns 2,658 shares of the medical equipment provider’s stock worth $395,000 after purchasing an additional 72 shares in the last quarter. TrinityPoint Wealth LLC lifted its holdings in Steris by 3.4% in the 2nd quarter. TrinityPoint Wealth LLC now owns 2,267 shares of the medical equipment provider’s stock worth $336,000 after purchasing an additional 75 shares in the last quarter. CWM LLC lifted its holdings in Steris by 130.9% in the 3rd quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 106 shares in the last quarter. Parallel Advisors LLC lifted its holdings in Steris by 7.6% in the 3rd quarter. Parallel Advisors LLC now owns 1,664 shares of the medical equipment provider’s stock worth $240,000 after purchasing an additional 117 shares in the last quarter. Finally, Squar Milner Financial Services LLC lifted its holdings in Steris by 225.9% in the 3rd quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 122 shares in the last quarter. Institutional investors own 88.11% of the company’s stock.

Separately, ValuEngine cut Steris from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $148.20.

In other news, VP John Adam Zangerle sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $142.15, for a total transaction of $142,150.00. Also, VP Renato Tamaro sold 2,065 shares of the company’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $153.15, for a total value of $316,254.75. The disclosure for this sale can be found here. 2.36% of the stock is owned by corporate insiders.

NYSE STE opened at $144.69 on Tuesday. The stock’s 50 day moving average is $142.09 and its 200 day moving average is $143.34. The company has a current ratio of 2.41, a quick ratio of 1.87 and a debt-to-equity ratio of 0.37. Steris PLC has a 12 month low of $99.14 and a 12 month high of $156.66. The stock has a market cap of $12.38 billion, a PE ratio of 29.59 and a beta of 0.88.

Steris (NYSE:STE) last posted its quarterly earnings results on Monday, November 4th. The medical equipment provider reported $1.32 EPS for the quarter, topping the Zacks’ consensus estimate of $1.26 by $0.06. Steris had a return on equity of 14.28% and a net margin of 11.59%. The company had revenue of $736.84 million for the quarter, compared to analysts’ expectations of $717.79 million. During the same period in the previous year, the firm earned $1.10 EPS. The firm’s revenue was up 8.5% compared to the same quarter last year. On average, analysts forecast that Steris PLC will post 5.61 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Tuesday, November 26th will be issued a dividend of $0.37 per share. The ex-dividend date is Monday, November 25th. This represents a $1.48 annualized dividend and a dividend yield of 1.02%. Steris’s dividend payout ratio (DPR) is 30.27%.

About Steris

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Further Reading: What is a back-end load?

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.